CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer
CG Willett, WJ Daly, AL Warshaw - The American journal of surgery, 1996 - Elsevier
PURPOSE: This study examines the changes of serum levels of CA 19-9 in patients with
pancreatic cancer following neoadjuvant irradiation and chemotherapy to define the
potential role of this tumor marker in preoperative management of these patients.
MATERIALS AND METHODS: Serum CA 19-9 levels were measured in 42 patients before
receiving external beam irradiation with concurrent 5-fluorouracil in preparation for
laparotomy and Whippie procedure or intraoperative irradiation (IORT). The CA 19-9 levels …
pancreatic cancer following neoadjuvant irradiation and chemotherapy to define the
potential role of this tumor marker in preoperative management of these patients.
MATERIALS AND METHODS: Serum CA 19-9 levels were measured in 42 patients before
receiving external beam irradiation with concurrent 5-fluorouracil in preparation for
laparotomy and Whippie procedure or intraoperative irradiation (IORT). The CA 19-9 levels …
